Sign up to save your podcasts
Or
Share RC: Let’s Get Honest About Decentralized Clinical Trials with Hassan Kadhim, Global Head of Clinical Trial Business Capabilities at Bristol-Myers Squibb
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
RC: Let’s Get Honest About Decentralized Clinical Trials with Hassan Kadhim, Global Head of Clinical Trial Business Capabilities at Bristol-Myers Squibb
Let’s clarify what decentralized clinical trials are before this bubble bursts!
In this episode, Hassan Kadhim, global head of clinical trial business capabilities at Bristol-Myers Squibb, takes a very sober look at decentralized clinical trials: what they mean to him, how they are evolving, and why they are here to stay. To incentivize progress around DCTs, Bristol-Myers Squibb came up with a definition for the term “decentralized clinical trial” that enlists four traditional capabilities and four up-and-coming ones, all of which Hassan explains. He discusses the design and coordination for the implementation of DCTs to collect the necessary patient data in a comfortable burdenless manner. Not all countries, organizations, or sites are ready to implement DCTs; Hassan thinks ever since COVID, the industry has changed in that way.
Tune in to this episode to hear more about DCTs from Hassan and learn where they’re taking the research industry!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
View all episodes
By Saul Marquez
4.9
111111 ratings
Let’s clarify what decentralized clinical trials are before this bubble bursts!
In this episode, Hassan Kadhim, global head of clinical trial business capabilities at Bristol-Myers Squibb, takes a very sober look at decentralized clinical trials: what they mean to him, how they are evolving, and why they are here to stay. To incentivize progress around DCTs, Bristol-Myers Squibb came up with a definition for the term “decentralized clinical trial” that enlists four traditional capabilities and four up-and-coming ones, all of which Hassan explains. He discusses the design and coordination for the implementation of DCTs to collect the necessary patient data in a comfortable burdenless manner. Not all countries, organizations, or sites are ready to implement DCTs; Hassan thinks ever since COVID, the industry has changed in that way.
Tune in to this episode to hear more about DCTs from Hassan and learn where they’re taking the research industry!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
More shows like Outcomes Rocket
View all
WSJ What’s News
4,333 Listeners
HBR IdeaCast
1,827 Listeners
WSJ Your Money Briefing
1,748 Listeners
The McKinsey Podcast
380 Listeners
Planet Money
30,856 Listeners
Bloomberg Intelligence
401 Listeners
Coaching for Leaders
1,456 Listeners
a16z Podcast
1,027 Listeners
Up First from NPR
56,027 Listeners
KFF Health News' 'What the Health?'
480 Listeners
The Daily Stoic
4,741 Listeners
Becker’s Healthcare Podcast
183 Listeners
Morning Brew Daily
2,962 Listeners
Think Fast Talk Smart: Communication Techniques
793 Listeners
Chasing Life
8,213 Listeners